Robert N Nishimura

USPTO Granted Patents = 10 (Patent Applications = 9)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 18(Granted Patents)

Location History:

Santa Monica, CA (US) (2017 - 2021)
Sepulveda, CA (US) (2016 - 2022)

Company Filing History:

9 out of 889

The United States Government As Represented by the Department of Veterans Affairs

University of California

patents

4. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12195550 - Targeting intracellular target-binding determinants with intracellular antibodies (2025-01-14),

2. 12116416 - Targeting intracellular target-binding determinants with intracellular antibodies (2024-10-15),

3. 11453725 - Methods for DNA-dependent targeting of a cell permeant antibody (2022-09-27),

4. 10961301 - Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair (2021-03-30),

5. 10703807 - Antibody-mediated transduction of heat shock proteins into living cells (2020-07-07),

6. 10683363 - Targeting intracellular target-binding determinants with intracellular antibodies (2020-06-16),

7. 10383945 - Methods for DNA-dependent targeting of a cell permeant antibody (2019-08-20),

8. 9732146 - Antibody-mediated transduction of heat shock proteins into living cells (2017-08-15),

9. 9701740 - Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair (2017-07-11),

10. 9283272 - Targeting intracellular target-binding determinants with intracellular antibodies (2016-03-15),

Title: The Innovative Contributions of Robert N. Nishimura

Introduction

Robert N. Nishimura is a prominent inventor based in Sepulveda, California. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. With a total of 10 patents to his name, Nishimura's work has the potential to impact various medical applications.

Latest Patents

One of his latest patents is titled "Targeting intracellular target-binding determinants with intracellular antibodies." This invention provides a method for inhibiting an intracellular target in a cell using a bispecific antibody. The method involves contacting the cell with a bispecific antibody that has a first Fv fragment with a cell-penetrating determinant and a second Fv fragment with an intracellular target-binding determinant. Under suitable conditions, the first Fv fragment allows the bispecific antibody to enter the cell, while the second Fv fragment binds to the intracellular target, thereby inhibiting it.

Career Highlights

Throughout his career, Robert N. Nishimura has worked with notable organizations, including the United States Government as represented by the Department of Veterans Affairs and Yale University. His experience in these institutions has contributed to his expertise in the field of biotechnology and antibody development.

Collaborations

Nishimura has collaborated with esteemed colleagues such as Richard H. Weisbart and James E. Hansen. These collaborations have likely enriched his research and innovation efforts.

Conclusion

Robert N. Nishimura's innovative work in the field of bispecific antibodies showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving therapeutic methods for intracellular targets.

This text is generated by artificial intelligence and may not be accurate.